Genetic instability |
Larger nuclei |
Human melanoma and liposarcoma |
Hida et al. (2004)
|
|
Chromosomal translocations |
B-cell lymphomas |
Streubel et al. (2004)
|
|
Aneuploid |
Breast cancer |
Lin et al. (2017)
|
|
Genomic transfer |
Cell fusion/cell-in-cell structure |
Glinsky (2005),
Wang et al. (2023)
|
Genetic heterogeneity |
Heterogeneous gene expression patterns |
Influenced by tumour type, extracellular environment, and epigenetic regulation |
Aird (2009),
Hennigs et al. (2021)
|
|
Upregulated genes involved in angiogenesis (VEGFR1/2), cell proliferation and motility, stemness and drug resistance |
|
Matsuda et al. (2010),
Ohga et al. (2012)
|
|
Survival capacity in serum-free medium |
|
Bussolati et al. (2003)
|
|
Upregulated extracellular matrix organisation genes such as COL4A2 and SPARC, and vascular endothelial cell markers such as CD31, AQP1 and CD34 |
Hepatocellular carcinoma |
Aizarani et al. (2019)
|
Anoikis resistance |
Resistance to anoikis |
miR-145, Bcl-2, syndecan-4 |
Yadav et al. (2015),
Hida et al. (2017),
Onyeisi et al. (2020)
|
|
Protected tumour cells from anoikis in circulation and helped them to migrate to distant organs |
|
Pyaskovskaya et al. (2021)
|
Abnormal metabolism |
Closely associated with glycolysis and oxidative stress |
COX-2, PFKFB3, TRPM7, CA2 |
Cantelmo et al. (2016),
Wu et al. (2018),
Zhang et al. (2018),
Annan et al. (2019),
Wu et al. (2023)
|
Resistance to anticancer drugs |
ABCB1-postive TEC increased after first-line chemotherapy |
Urothelial carcinoma |
Kikuchi et al. (2020)
|
|
Resistant to paclitaxel |
Human melanoma cell xenografts, MDR1 |
Akiyama et al. (2012)
|
|
Resistant to doxorubicin and 5-fluorouracil |
Hepatocellular carcinoma, CD105 |
Xiong et al. (2009)
|
|
Resistant to the checkpoint blockade immunotherapy |
Advanced non-small cell lung cancer, PD-L1 |
Zhang et al. (2020)
|
Adaptive to abnormal mechanical microenvironment |
Inhibited leukocyte rolling but promoted their adhesion |
Increased extracellular matrix stiffness; increased interstitial pressure and reduced blood flow/shear stress |
Finger et al. (1996),
Paszek et al. (2005)
|
|
Specific mechanical responsiveness |
Independent of Inflammatory signalling; dependent on extracellular matrix composition |
Onken et al. (2014),
Riddle et al. (2022)
|